Encompass Health Corp (EHC)
85.45
+0.01
(+0.01%)
USD |
NYSE |
May 17, 16:00
85.46
+0.01
(+0.01%)
After-Hours: 20:00
Encompass Health Cash from Financing (Quarterly): -40.60M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -40.60M |
December 31, 2023 | -29.90M |
September 30, 2023 | -65.80M |
June 30, 2023 | -43.50M |
March 31, 2023 | -58.00M |
December 31, 2022 | -16.50M |
September 30, 2022 | -49.00M |
June 30, 2022 | -19.30M |
March 31, 2022 | -60.90M |
December 31, 2021 | 42.30M |
September 30, 2021 | -18.50M |
June 30, 2021 | -186.40M |
March 31, 2021 | -77.50M |
December 31, 2020 | -354.20M |
September 30, 2020 | -45.60M |
June 30, 2020 | 182.80M |
March 31, 2020 | 71.10M |
December 31, 2019 | -424.10M |
September 30, 2019 | 431.80M |
June 30, 2019 | 122.20M |
March 31, 2019 | -81.70M |
December 31, 2018 | -67.70M |
September 30, 2018 | -137.00M |
June 30, 2018 | 0.20M |
March 31, 2018 | -116.70M |
Date | Value |
---|---|
December 31, 2017 | -89.30M |
September 30, 2017 | -100.80M |
June 30, 2017 | -63.50M |
March 31, 2017 | -106.30M |
December 31, 2016 | -88.10M |
September 30, 2016 | -120.70M |
June 30, 2016 | -89.10M |
March 31, 2016 | -118.50M |
December 31, 2015 | 76.60M |
September 30, 2015 | 645.50M |
June 30, 2015 | -184.70M |
March 31, 2015 | 85.30M |
December 31, 2014 | 438.80M |
September 30, 2014 | 122.20M |
June 30, 2014 | -76.10M |
March 31, 2014 | -50.70M |
December 31, 2013 | -72.40M |
September 30, 2013 | -50.50M |
June 30, 2013 | -63.30M |
March 31, 2013 | -126.20M |
December 31, 2012 | -85.20M |
September 30, 2012 | 50.90M |
June 30, 2012 | -61.80M |
March 31, 2012 | -33.90M |
December 31, 2011 | -89.70M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-424.10M
Minimum
Dec 2019
431.80M
Maximum
Sep 2019
-31.98M
Average
-42.05M
Median
Cash from Financing (Quarterly) Benchmarks
DaVita Inc | 319.32M |
Pediatrix Medical Group Inc | 76.20M |
US Physical Therapy Inc | -4.49M |
The Oncology Institute Inc | -0.938M |
American Oncology Network Inc | -0.254M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 238.80M |
Cash from Investing (Quarterly) | -129.70M |
Free Cash Flow | 239.00M |
Free Cash Flow Per Share (Quarterly) | 0.9726 |
Free Cash Flow to Equity (Quarterly) | 103.80M |
Free Cash Flow to Firm (Quarterly) | 127.04M |
Free Cash Flow Yield | 2.75% |